Syensqo
Short position disclosed on July 24, 2026.
0.89% of the capital sold short
1 disclosing funds
1 disclosures on record
BE0974464977 ISIN code
Funds holding Syensqo Titelia
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Jul 28Aug 1Aug 5Aug 9Aug 13
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Marshall Wace LLP | 0.89% | unchanged | July 24, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 24, 2026 | Marshall Wace LLP | 0.89% | still open |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Syensqo, source FSMA, data as at July 24, 2026, https://www.quivad.com/action/syensqo